Assignment of Assignor's Interest

Recorded: 2016-06-30 Pages: 7

Assignor

Executed: 2016-01-26

Assignee

NLS-1 PHARMA AG

BEITENWEG 10, 6370 STANSS, NIDWALD, SWITZERLAND

Covered Property (1)

Phacetoperane for the Treatment of Attention-Deficit Hyperactivity Disorder

Application: 14/360,355 →

Publication: US 2015/0038533

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.